Action of Triton X-100 on lipids and proteolipids of nerve-ending membranes.
D000818:Animals; D002458:Cell Fractionation; D002462:Cell Membrane / Q000187:drug effects* / Q000378:metabolism; D002540:Cerebral Cortex / Q000187:drug effects; D002784:Cholesterol / Q000378:metabolism; D050356:Lipid Metabolism; D008074:Lipoproteins / Q000378:metabolism*; D008566:Membranes / Q000187:drug effects; D008928:Mitochondria / Q000187:drug effects; D009186:Myelin Sheath / Q000187:drug effects; D009411:Nerve Endings / Q000187:drug effects* / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000378:metabolism*; D010743:Phospholipids / Q000378:metabolism; D051381:Rats; D013501:Surface-Active Agents / Q000494:pharmacology*; D013569:Synapses / Q000187:drug effects
D008074:Lipoproteins; D009419:Nerve Tissue Proteins; D010743:Phospholipids; D013501:Surface-Active Agents; D002784:Cholesterol